| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |